Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib after radical prostatectomy for morphine-sparing postoperative analgesia
2005-006026-28Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of parecoxib in postoperative pain (2 arms), sponsored by Pfizer. Primary endpoint: Total cumulative morphine use in the first 24 hours after surgery. Started Jun 2006; status: terminated.
02
Drugs
parecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2005-006026-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006026-28.